92 related articles for article (PubMed ID: 15725172)
21. Cost implications for the treatment of five oral lesions commonly found in HIV/AIDS.
Adedigba MA; Naidoo S; Ogunbodede EO
Odontostomatol Trop; 2009 Mar; 32(125):17-24. PubMed ID: 19711837
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
23. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
24. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
25. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
Yang YL; Lo HJ; Hung CC; Li Y
BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
27. Oral and constitutional manifestations of HIV-infected hospital patients in Northern Vietnam.
Jensen TO; Tam VV; Mai NT; Ut do Q; Dat DD; Lien NT; Nga NT; Bygbjerg IC
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1459-68. PubMed ID: 16610648
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
Chiao EY; Giordano TP; Richardson P; El-Serag HB
J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
[TBL] [Abstract][Full Text] [Related]
29. Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba.
Carpio E; López V; Fardales V; Benítez I
J Oral Pathol Med; 2009 Jan; 38(1):126-31. PubMed ID: 19192058
[TBL] [Abstract][Full Text] [Related]
30. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
31. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
32. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
33. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil.
Lourenço AG; Figueiredo LT
Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E281-6. PubMed ID: 18449110
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
Siddiqui U; Bini EJ; Chandarana K; Leong J; Ramsetty S; Schiliro D; Poles M
J Clin Gastroenterol; 2007; 41(5):484-90. PubMed ID: 17450031
[TBL] [Abstract][Full Text] [Related]
35. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
[TBL] [Abstract][Full Text] [Related]
36. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
38. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002.
Sanchez TH; Brooks JT; Sullivan PS; Juhasz M; Mintz E; Dworkin MS; Jones JL;
Clin Infect Dis; 2005 Dec; 41(11):1621-7. PubMed ID: 16267735
[TBL] [Abstract][Full Text] [Related]
39. Risk indicators for HIV-associated jointly occurring oral candidiasis and oral hairy leukoplakia.
Chattopadhyay A; Patton LL
AIDS Patient Care STDS; 2007 Nov; 21(11):825-32. PubMed ID: 18240892
[TBL] [Abstract][Full Text] [Related]
40. Oral manifestations of HIV in a southeast USA population.
Patton LL; McKaig RG; Strauss RP; Eron JJ
Oral Dis; 1998 Sep; 4(3):164-9. PubMed ID: 9972166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
